+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Genome Testing Market by Component (Consumables, Equipment, Software & Services), Technology (Microarrays, Next-Generation Sequencing, Targeted Sequencing), Application, Distribution Channel, End-use - Forecast 2024-2030- Product Image
Global Genome Testing Market by Component (Consumables, Equipment, Software & Services), Technology (Microarrays, Next-Generation Sequencing, Targeted Sequencing), Application, Distribution Channel, End-use - Forecast 2024-2030- Product Image
Sale

Global Genome Testing Market by Component (Consumables, Equipment, Software & Services), Technology (Microarrays, Next-Generation Sequencing, Targeted Sequencing), Application, Distribution Channel, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5925226
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Genome Testing Market size was estimated at USD 17.57 billion in 2023, USD 19.76 billion in 2024, and is expected to grow at a CAGR of 13.21% to reach USD 41.90 billion by 2030.

Genome Testing, often referred to as whole genome sequencing (WGS), involves examining the complete sequence of DNA in an organism’s genome at a single time. This comprehensive analysis covers all types of genetic variations, including insertions, deletions, single nucleotide polymorphisms (SNPs), copy number variations, and large structural changes.

Growing emphasis on early disease detection & prevention, along with the increasing interest in ancestry and genealogy, boosts the significance of genome testing. However, the high cost associated with genomics equipment and the complexity of interpreting genetic information impact the market growth. Furthermore, the integration of AI and big data analytics for improved interpretation of genetic data is creating a potential opportunity for market growth.

Regional Insights

In the Americas, particularly in the United States and Canada, the consumer need for genome testing is driven by a heightened awareness of personalized medication and a growing focus on preventive healthcare procedures. Customers in these regions exhibit a willingness to invest in health and wellness, supported by higher disposable income and substantial healthcare spending. The increasing prevalence of genetic disorders has catalyzed the demand for genome testing services. The European Union displays a diverse market for genome testing due to differences in healthcare systems, regulations, and consumer attitudes across member countries.

Privacy concerns, ethical considerations, and regulatory frameworks such as the General Data Protection Regulation (GDPR) profoundly influence customer purchasing behavior. Emerging economies in the MEA show varying levels of demand for genome testing. The Middle East, with its well-funded healthcare systems in countries, is witnessing an increased interest in genome testing for personalized medicine. The Asia Pacific region, especially China, Japan, and India, exhibits a rapidly developing market for genome testing. China's investment in biotechnology has soared, as evidenced by its large-scale genome research projects and international collaborations.

Market Trends by Segment

  • Component: Ongoing advancements in equipments for high-throughput sequencing
  • Technology: Increasing preference of next-generation sequencing due to its precise and comprehensive genomic analysis
  • Application: Increasing investment for advance genome testing across
  • End-use: Rising significance of advanced genomic in diagnostic laboratories for research associated with genetic diseases

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Cone Health Readies for 100,000 Person Genomics Project

Cone Health is on the brink of launching an expansive genomic testing initiative designed to enhance the health and longevity of individuals throughout the Piedmont Triad region. The program aims to harness the predictive power of genomics to identify individuals at risk for certain diseases, such as breast cancer and cardiac issues, thereby enabling early intervention and personalized healthcare. Cone Health has partnered with population genomics specialist, Helix, and envisages recruiting 100,000 healthy volunteers within five years for DNA sequencing via blood or saliva samples.

Illumina Launches Advanced Liquid Biopsy Assay to Enable Comprehensive Genomic Profiling of Solid Tumors

Illumina Inc. has unveiled its latest innovation, the TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2), designed for the comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) using a noninvasive liquid biopsy approach. The TSO 500 ctDNA v2 presents a significant advancement for cancer research, offering a viable solution for genomic profiling when tissue samples are unattainable or enhancing the insights gained from traditional tissue-based tests.

Apollo Opens Genomic Institute In Chennai, to Open Three More in 2023

Apollo Hospitals Group has inaugurated a Genomics Institute in Chennai to advance the study of genes and tackle genetic disorders. This marks the newest addition to their growing network with existing facilities in Mumbai and Delhi. By the end of 2023, Apollo is poised to enhance its genomic footprint with additional institutes launching in Hyderabad, Bangalore, and Ahmedabad. The Chennai Institute is set to offer comprehensive genomic services, including genetic evaluation, clinical diagnostics, obstetric genetics, and cancer genomics. These services are meticulously designed to provide patients with critical information for the management and prevention of genetic disorders.

Key Company Profiles

The report delves into recent significant developments in the Genome Testing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, 23andMe, Inc, Abbott Laboratories, Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche, Ltd., Freenome Holdings, Inc., GeneDx, LLC, Genomic Testing Cooperative, Helix OpCo, LLC, Illumina, Inc., Merck KGaA, New England Biolabs, Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Takara Bio Inc, Thermo Fisher Scientific Inc., Ultima Genomics, Inc., and VWR International, LLC.

This research report offers invaluable insights into various crucial aspects of the Genome Testing Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of genetic disorders and cancer across the globe
5.1.1.2. Growing emphasis on early disease detection & prevention
5.1.1.3. Increasing awareness of personalized medicine
5.1.2. Restraints
5.1.2.1. High cost associated with genomics equipment
5.1.3. Opportunities
5.1.3.1. Technological advancements in gene sequencing and data analysis
5.1.3.2. Rising government initiatives and fundings for boosting research activities
5.1.4. Challenges
5.1.4.1. Complexities associated with the interpreting genetic information
5.2. Market Segmentation Analysis
5.2.1. Component: Ongoing advancements in equipments for high-throughput sequencing
5.2.2. Technology: Increasing preference of next-generation sequencing due to its precise and comprehensive genomic analysis
5.2.3. Application: Increasing investment for advance genome testing across
5.2.4. End-use: Rising significance of advanced genomic in diagnostic laboratories for research associated with genetic diseases
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Genome Testing Market, by Component
6.1. Introduction
6.2. Consumables
6.3. Equipment
6.4. Software & Services
7. Genome Testing Market, by Technology
7.1. Introduction
7.2. Microarrays
7.3. Next-Generation Sequencing
7.4. Targeted Sequencing
7.5. Whole Genome Sequencing
8. Genome Testing Market, by Application
8.1. Introduction
8.2. Cancer
8.3. Non-cancer
9. Genome Testing Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Genome Testing Market, by End-use
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals & Clinics
11. Americas Genome Testing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Genome Testing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Genome Testing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Cone Health Readies for 100,000 Person Genomics Project
14.3.2. Illumina Launches Advanced Liquid Biopsy Assay to Enable Comprehensive Genomic Profiling of Solid Tumors
14.3.3. Apollo Opens Genomic Institute In Chennai, to Open Three More in 2023
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. GENOME TESTING MARKET RESEARCH PROCESS
FIGURE 2. GENOME TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENOME TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENOME TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 16. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. GENOME TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. GENOME TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENOME TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENOME TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GENOME TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GENOME TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GENOME TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GENOME TESTING MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GENOME TESTING MARKET SIZE, BY BRAIN CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GENOME TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GENOME TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GENOME TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GENOME TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GENOME TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GENOME TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL GENOME TESTING MARKET SIZE, BY MELANOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL GENOME TESTING MARKET SIZE, BY MELANOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL GENOME TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL GENOME TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL GENOME TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL GENOME TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL GENOME TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL GENOME TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL GENOME TESTING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL GENOME TESTING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL GENOME TESTING MARKET SIZE, BY TUMORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL GENOME TESTING MARKET SIZE, BY TUMORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL GENOME TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL GENOME TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 111. CANADA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 112. CANADA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 113. CANADA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 114. CANADA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 115. CANADA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. CANADA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. CANADA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 118. CANADA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 119. CANADA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 120. CANADA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 121. CANADA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. CANADA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. CANADA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 124. CANADA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 125. MEXICO GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 126. MEXICO GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 127. MEXICO GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 128. MEXICO GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 129. MEXICO GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. MEXICO GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. MEXICO GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 132. MEXICO GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 133. MEXICO GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 134. MEXICO GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 135. MEXICO GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 136. MEXICO GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 137. MEXICO GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 138. MEXICO GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. AUSTRALIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 178. AUSTRALIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. AUSTRALIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 184. AUSTRALIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 185. CHINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 186. CHINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 187. CHINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. CHINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. CHINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. CHINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. CHINA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 192. CHINA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 193. CHINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 194. CHINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 195. CHINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. CHINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. CHINA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 198. CHINA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 199. INDIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 200. INDIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 201. INDIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 202. INDIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 203. INDIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. INDIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. INDIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 206. INDIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 207. INDIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 208. INDIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 209. INDIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 210. INDIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 211. INDIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 212. INDIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. INDONESIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 220. INDONESIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. INDONESIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 226. INDONESIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 227. JAPAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 228. JAPAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 229. JAPAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. JAPAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. JAPAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. JAPAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. JAPAN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 234. JAPAN GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 235. JAPAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 236. JAPAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 237. JAPAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. JAPAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. JAPAN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 240. JAPAN GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. MALAYSIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 248. MALAYSIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 253. MALAYSIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 254. MALAYSIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. PHILIPPINES GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 262. PHILIPPINES GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 267. PHILIPPINES GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 268. PHILIPPINES GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. SINGAPORE GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 276. SINGAPORE GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. SINGAPORE GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 282. SINGAPORE GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. SOUTH KOREA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 290. SOUTH KOREA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 295. SOUTH KOREA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 296. SOUTH KOREA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. TAIWAN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 304. TAIWAN GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 309. TAIWAN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 310. TAIWAN GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 311. THAILAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 312. THAILAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 313. THAILAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 314. THAILAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 315. THAILAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. THAILAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. THAILAND GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 318. THAILAND GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 319. THAILAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 320. THAILAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 321. THAILAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 322. THAILAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 323. THAILAND GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 324. THAILAND GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 325. VIETNAM GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 326. VIETNAM GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 327. VIETNAM GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 328. VIETNAM GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 329. VIETNAM GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. VIETNAM GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. VIETNAM GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 332. VIETNAM GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 333. VIETNAM GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 334. VIETNAM GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 335. VIETNAM GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 336. VIETNAM GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 337. VIETNAM GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 338. VIETNAM GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 355. DENMARK GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 356. DENMARK GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 357. DENMARK GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 358. DENMARK GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 359. DENMARK GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 360. DENMARK GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 361. DENMARK GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
TABLE 362. DENMARK GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
TABLE 363. DENMARK GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
TABLE 364. DENMARK GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
TABLE 365. DENMARK GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 366. DENMARK GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 367. DENMARK GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 368. DENMARK

Companies Mentioned

  • 10x Genomics
  • 23andMe, Inc
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche, Ltd.
  • Freenome Holdings, Inc.
  • GeneDx, LLC
  • Genomic Testing Cooperative
  • Helix OpCo, LLC
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Novogene Co, Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc.
  • Ultima Genomics, Inc.
  • VWR International, LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 19.76 Billion
Forecasted Market Value ( USD ) by 2030 $ 41.9 Billion
Compound Annual Growth Rate13.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Personal Genome Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Personal Genome Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 109 Pages
  • Global
From
Global Direct-to-Consumer Genetic Testing Market Size, Share & Trends Analysis Report by Test Type (Nutrigenomics, Carrier), Technology (Whole Genome Sequencing), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Direct-to-Consumer Genetic Testing Market Size, Share & Trends Analysis Report by Test Type (Nutrigenomics, Carrier), Technology (Whole Genome Sequencing), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Single Cell Genome Sequencing Market Size, Share & Trends Analysis By Product Type (Instruments, Reagents), By Disease Area (Cancer, Immunology), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Single Cell Genome Sequencing Market Size, Share & Trends Analysis By Product Type (Instruments, Reagents), By Disease Area (Cancer, Immunology), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 185 Pages
  • Global
From
Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 - Product Image

Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028

  • Report
  • 115 Pages
  • Global
From
Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027 - Product Image

Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027

  • Report
  • 642 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.